John W. Rogers Jr.
Ariel Appreciation Fund
John W. Rogers Jr. Cardinal Health Inc stake
total: 73
Ariel Appreciation Fund CAH trades
- Total transactions:
- 11
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 7
- Held since:
- 2019 Q3
- Held for:
- 15 quarters
- Latest activity:
- 2023 Q2
According to 2026 Q2 report, John W. Rogers Jr. doesn't hold any Cardinal Health Inc (CAH) shares. To date, the estimated cost basis is nearly $50.14 for "buy" trades and estimated average "sell" price is $66.18. Ariel Appreciation Fund first purchased CAH in 2019 Q3, initially acquiring 568,500 shares. Since the initial investment in Cardinal Health Inc (CAH), Ariel Appreciation Fund has made 10 more transactions.
When did John W. Rogers Jr. sell Cardinal Health Inc (CAH)?
John W. Rogers Jr. sold off the entire Cardinal Health Inc (CAH) position in 2023 Q2.
When did John W. Rogers Jr. buy Cardinal Health Inc (CAH)?
John W. Rogers Jr. first invested in Cardinal Health Inc (CAH) in 2019 Q3 at the reported quarter-end price of $47.19 per share.
What's the cost basis of Ariel Appreciation Fund's CAH stake?
The estimated cost basis for Cardinal Health Inc (CAH) stake is around $50.14 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $50.14
- Weighted AVG sell price:
- $66.18
John W. Rogers Jr.'s historical trades in Cardinal Health Inc
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$75.50
|
|
-100% (-152,395)
|
-1%
|
|
2023 Q1
|
1.00%
|
152,395
|
$75.50
|
$11,505,822
|
-26.83% (-55,873)
|
-0.37%
|
|
2022 Q4
|
1.41%
|
208,268
|
$76.87
|
$16,009,561
|
-43.97% (-163,425)
|
-1.24%
|
|
2022 Q3
|
2.44%
|
371,693
|
$66.68
|
$24,784,489
|
-30.79% (-165,385)
|
-1%
|
|
2022 Q2
|
2.56%
|
537,078
|
$52.27
|
$28,073,067
|
-8.57% (-50,353)
|
-0.2%
|
|
2022 Q1
|
2.58%
|
587,431
|
$56.70
|
$33,307,338
|
-8.13% (-51,984)
|
-0.21%
|
|
2021 Q1
|
2.89%
|
639,415
|
$60.75
|
$38,844,461
|
+22.84% (+118,900)
|
+0.54%
|
|
2020 Q4
|
2.37%
|
$53.56
|
+30.38% (+121,300)
|
|||
|
2020 Q2
|
2.18%
|
$52.19
|
-8.73% (-38,200)
|
|||
|
2019 Q4
|
1.68%
|
$50.58
|
-23.06% (-131,085)
|
|||
|
2019 Q3
|
2.07%
|
$47.19
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.